Related Experiment Video
Updated: Feb 18, 2026
10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
8.2K
Tumour boards in geriatric oncology
Tanya Marya Wildes1, Anita O'Donovan2, Giuseppe Ferdinando Colloca3
1Washington University School of Medicine, St. Louis, MO, USA.
Age and Ageing
|November 18, 2017
Summary
Integrating geriatricians into multidisciplinary tumor boards can improve cancer care for older adults. This approach prioritizes quality of life and functional preservation alongside survival, enhancing treatment decisions.
Area of Science:
- Oncology
- Geriatrics
- Cancer Care
Background:
- Multidisciplinary tumor boards (MTBs) are crucial for cancer treatment planning.
- Current MTBs primarily involve oncologists, focusing narrowly on cancer itself.
- Older adults require a shift in treatment goals towards functional preservation and quality of life.
Purpose of the Study:
- To explore the benefits of integrating geriatricians into multidisciplinary tumor boards.
- To enhance cancer treatment decisions for the older adult population.
Main Methods:
- Review of existing literature on MTBs and geriatric oncology.
- Analysis of the role of Comprehensive Geriatric Assessment (CGA) in cancer care.
- Discussion on the potential impact of geriatrician input in MTBs.
Main Results:
- While survival benefits of MTBs are not definitively proven, other advantages exist.
- Comprehensive Geriatric Assessment and geriatrician input show increasing benefits for older cancer patients.
- Geriatricians can provide crucial insights into the specific needs of older adults.
Conclusions:
- The integration of geriatricians into MTBs should be urgently considered.
- This integration can optimize cancer treatment planning for older adults, focusing on holistic care.
- Prioritizing functional preservation and quality of life is key in geriatric oncology.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.0K
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
9.5K
Related Concept Videos
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
01:21Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787